Pay in 4 interest-free payments of $5.05 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Programa Certified for Sport
A new study found that women who combine GLP-1s and HRT lose more fat than women on GLP-1s alone, but more research is still needed
The clinical insights from these studies demonstrate how our portfolio may offer more tailored, individualised treatment options for people living with obesity. The data presented on Roches obesity assets include: Enicepatide (CT-388) : Late-breaking data from the Phase II (CT388-103) study will highlight clinical weight loss outcomes from investigational enicepatide in people living with overweight/obesity
High performance
Proposes a mechanistic classification framework for pain in cirrhosis (nociceptive, neuropathic, nociplastic) and argues for phenotype-directed treatment approaches
US$ 20.87
US$ 22.79
US$ 25.91
